Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 129 Total
MBIO - Mustang Bio Inc - Stock Price Chart
TickerMBIO [NASD]
CompanyMustang Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap24.01MEPS (ttm)-4.62
P/E-EPS this Y89.83%
Forward P/E-EPS next Y42.62%
PEG-EPS past 5Y18.87%
P/S-EPS next 5Y-
P/B-EPS Q/Q77.63%
Dividend-Sales Q/Q-
Insider Own20.31%Inst Own3.14%
Insider Trans0.00%Inst Trans-65.99%
Short Float10.36%EarningsMay 10
Analyst Recom1.00Target Price10.00
Avg Volume20.88M52W Range0.13 - 8.17
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Worcester, MA.
RKLB - Rocket Lab USA Inc - Stock Price Chart
TickerRKLB [NASD, RUT]
CompanyRocket Lab USA Inc
CountryUSA
IndustryAerospace & Defense
Market Cap2.42BEPS (ttm)-0.37
P/E-EPS this Y-31.72%
Forward P/E-EPS next Y41.51%
PEG-EPS past 5Y-
P/S8.57EPS next 5Y-
P/B5.05EPS Q/Q5.74%
Dividend-Sales Q/Q68.99%
Insider Own38.91%Inst Own30.14%
Insider Trans-0.10%Inst Trans-0.26%
Short Float18.67%EarningsMay 06/a
Analyst Recom1.42Target Price7.29
Avg Volume7.26M52W Range3.47 - 8.05
Rocket Lab USA, Inc. is an aerospace company, which engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment includes space engineering, program management, satellite components, spacecraft manufacturing, and mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Spice Adam C.Chief Financial OfficerMay 24 '24Sale4.2263,529267,9021,383,677May 28 06:30 PM
Kampani ArjunGeneral CounselMay 24 '24Sale4.2229,026122,403666,121May 28 06:34 PM
Spice Adam C.Chief Financial OfficerMar 05 '24Sale4.2567,160285,6311,442,206Mar 07 07:50 PM
Kampani ArjunGeneral CounselMar 05 '24Sale4.2531,394133,519695,147Mar 07 07:52 PM
Spice Adam C.Chief Financial OfficerNov 29 '23Sale4.4657,721257,6091,509,366Nov 30 07:49 PM
SMR - NuScale Power Corporation - Stock Price Chart
TickerSMR [NYSE, RUT]
CompanyNuScale Power Corporation
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap844.67MEPS (ttm)-0.84
P/E-EPS this Y32.24%
Forward P/E-EPS next Y20.16%
PEG-EPS past 5Y-
P/S45.22EPS next 5Y-
P/B6.62EPS Q/Q-32.36%
Dividend-Sales Q/Q-74.95%
Insider Own18.18%Inst Own31.96%
Insider Trans-1.05%Inst Trans4.26%
Short Float18.81%EarningsMay 09/a
Analyst Recom2.33Target Price7.62
Avg Volume5.78M52W Range1.81 - 11.21
NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by Jose N. Reyes in 2007 and is headquartered in Portland, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hopkins John LawrenceChief Executive OfficerMay 08 '24Sale6.0414,34586,64434,675May 10 04:09 PM
Temple Robert KGeneral CounselMay 06 '24Sale6.0723,806144,50219,054May 06 06:19 PM
Reyes Jose N JrChief Technology OfficerMay 03 '24Sale6.0415,77695,287478,306May 06 06:37 PM
Temple Robert KGeneral CounselMay 03 '24Sale6.048,87353,59342,860May 06 06:19 PM
Scott ClaytonChief Commercial OfficerMay 03 '24Sale6.047,19143,43443,549May 06 06:29 PM
KARO - Karooooo Ltd - Stock Price Chart
TickerKARO [NASD]
CompanyKarooooo Ltd
CountrySingapore
IndustrySoftware - Application
Market Cap1.00BEPS (ttm)1.28
P/E25.43EPS this Y14.73%
Forward P/E18.27EPS next Y17.56%
PEG22.91EPS past 5Y13.57%
P/S4.45EPS next 5Y1.11%
P/B6.49EPS Q/Q34.06%
Dividend2.62%Sales Q/Q9.96%
Insider Own74.98%Inst Own12.10%
Insider Trans0.00%Inst Trans2.50%
Short Float0.22%EarningsMay 15/a
Analyst Recom2.00Target Price31.30
Avg Volume7.57K52W Range18.59 - 37.11
Karooooo Ltd. engages in providing mobility data analytics solutions for the transportation industry. It operates through the following business segments: Cartrack, Carzuka, and Karooooo Logistics. The Cartrack segment provides an on-the-ground operational Internet of Things Software-as-a-service cloud. The Carzuka segment refers to a physical and e-commerce vehicle buying and selling marketplace. The Karooooo Logistics segment offers software applications enabling the management of last mile delivery and general operational logistics. It also operates through the South Africa, Africa-Other, Europe, and Asia-Pacific Middle East and U.S.A geographical segments. The company was founded on May 19, 2018 and is headquartered in Singapore.
VLCN - Volcon Inc - Stock Price Chart
TickerVLCN [NASD]
CompanyVolcon Inc
CountryUSA
IndustryAuto Manufacturers
Market Cap1.02MEPS (ttm)-28034.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.33EPS next 5Y-
P/B0.20EPS Q/Q95.12%
Dividend-Sales Q/Q-11.70%
Insider Own0.01%Inst Own0.39%
Insider Trans0.00%Inst Trans-
Short Float5.94%EarningsMay 08/b
Analyst Recom1.00Target Price67500.00
Avg Volume58.20K52W Range3.65 - 16425.00
Volcon, Inc. engages in the design and development of electric outdoor power sports vehicles. It also offers electric two and four-wheel motorcycles and utility terrain vehicles. The company was founded by Christian Gerard Okonsky and Adrian James on February 21, 2020 and is headquartered in Round Rock, TX.
DAWN - Day One Biopharmaceuticals Inc - Stock Price Chart
TickerDAWN [NASD, RUT]
CompanyDay One Biopharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap1.17BEPS (ttm)-2.49
P/E-EPS this Y-19.34%
Forward P/E-EPS next Y24.12%
PEG-EPS past 5Y-84.59%
P/S-EPS next 5Y-
P/B3.94EPS Q/Q-22.24%
Dividend-Sales Q/Q-
Insider Own30.65%Inst Own73.25%
Insider Trans-1.04%Inst Trans2.05%
Short Float17.59%EarningsMay 06/a
Analyst Recom1.55Target Price35.89
Avg Volume1.12M52W Range9.67 - 18.07
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blackman Samuel C.HEAD OF R&DJun 10 '24Sale12.6230,000378,5881,141,081Jun 12 04:29 PM
Bender JeremyCHIEF EXECUTIVE OFFICERMay 16 '24Sale16.087,873126,588654,728May 17 06:27 PM
Dubow AdamGENERAL COUNSELMay 16 '24Sale16.083,25352,30421,731May 17 06:11 PM
York Charles N IICOO, CFO AND SECRETARYMay 16 '24Sale16.082,67543,011224,868May 17 06:15 PM
Blackman Samuel C.HEAD OF R&DMay 16 '24Sale16.082,26736,4501,171,081May 17 06:18 PM
PDCO - Patterson Companies Inc. - Stock Price Chart
TickerPDCO [NASD, RUT]
CompanyPatterson Companies Inc.
CountryUSA
IndustryMedical Distribution
Market Cap2.27BEPS (ttm)2.00
P/E12.67EPS this Y2.33%
Forward P/E9.97EPS next Y8.14%
PEG1.41EPS past 5Y17.28%
P/S0.35EPS next 5Y9.00%
P/B2.27EPS Q/Q-3.10%
Dividend4.19%Sales Q/Q0.09%
Insider Own11.35%Inst Own87.52%
Insider Trans-0.01%Inst Trans-1.29%
Short Float4.28%EarningsJun 18/b
Analyst Recom2.64Target Price28.30
Avg Volume777.28K52W Range22.29 - 34.53
Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARRY KEVIN MICHAELChief Financial OfficerDec 19 '23Sale27.1856015,22121,674Dec 19 04:46 PM
Zurbay DonaldPresident & CEODec 06 '23Sale26.581,86849,651141,923Dec 07 05:18 PM
BARRY KEVIN MICHAELChief Financial OfficerDec 01 '23Sale25.361,62741,26123,103Dec 04 05:23 PM
ROGAN TIMOTHY EPresident - DentalOct 05 '23Sale29.759,260275,52540,382Oct 06 04:47 PM
Zurbay DonaldPresident & CEOJul 18 '23Sale32.485,620182,553149,539Jul 19 05:01 PM
SNGX - Soligenix Inc - Stock Price Chart
TickerSNGX [NASD]
CompanySoligenix Inc
CountryUSA
IndustryBiotechnology
Market Cap4.20MEPS (ttm)-11.84
P/E-EPS this Y43.04%
Forward P/E-EPS next Y0.00%
PEG-EPS past 5Y39.94%
P/S-EPS next 5Y1.00%
P/B3.63EPS Q/Q49.28%
Dividend-Sales Q/Q-
Insider Own0.23%Inst Own1.51%
Insider Trans0.00%Inst Trans-
Short Float1.43%EarningsMay 10/b
Analyst Recom1.00Target Price48.00
Avg Volume185.86K52W Range3.30 - 32.00
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.
HIMX - Himax Technologies ADR - Stock Price Chart
TickerHIMX [NASD]
CompanyHimax Technologies ADR
CountryTaiwan
IndustrySemiconductors
Market Cap1.29BEPS (ttm)0.28
P/E26.80EPS this Y60.90%
Forward P/E13.49EPS next Y17.72%
PEG-EPS past 5Y42.37%
P/S1.43EPS next 5Y-11.79%
P/B1.49EPS Q/Q-17.15%
Dividend4.23%Sales Q/Q-15.80%
Insider Own0.00%Inst Own13.32%
Insider Trans-Inst Trans-8.17%
Short Float3.56%EarningsMay 09/b
Analyst Recom2.00Target Price8.20
Avg Volume644.84K52W Range4.80 - 7.66
Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.
CMND - Clearmind Medicine Inc - Stock Price Chart
TickerCMND [NASD]
CompanyClearmind Medicine Inc
CountryCanada
IndustryBiotechnology
Market Cap3.90MEPS (ttm)-15.05
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-24.88%
P/S-EPS next 5Y-
P/B0.88EPS Q/Q98.32%
Dividend-Sales Q/Q-
Insider Own7.75%Inst Own8.79%
Insider Trans0.00%Inst Trans-
Short Float4.64%Earnings-
Analyst Recom-Target Price-
Avg Volume1.07M52W Range0.92 - 20.40
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
1234567891013